Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Transdermal Skin Patch, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Transdermal Skin Patch Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Transdermal Skin Patch Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Transdermal Skin Patch Market Size Growth Rate by Type
    • 1.4.2 Fentanyl Transdermal Skin Patch
    • 1.4.3 Nicotine Transdermal Skin Patch
    • 1.4.4 Clonidine Transdermal Skin Patch
    • 1.4.5 Buprenorphine Transdermal Skin Patch
  • 1.5 Market by Application
    • 1.5.1 Global Transdermal Skin Patch Market Size Growth Rate by Application
    • 1.5.2 Relieve Severe Pain
    • 1.5.3 Stop Smoking Cigarettes
    • 1.5.4 Treat An Overactive Bladder
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Skin Patch Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Transdermal Skin Patch Industry
      • 1.6.1.1 Transdermal Skin Patch Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Transdermal Skin Patch Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Transdermal Skin Patch Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Transdermal Skin Patch Market Size Estimates and Forecasts
    • 2.1.1 Global Transdermal Skin Patch Revenue 2015-2026
    • 2.1.2 Global Transdermal Skin Patch Sales 2015-2026
  • 2.2 Transdermal Skin Patch Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Transdermal Skin Patch Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Transdermal Skin Patch Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Transdermal Skin Patch Competitor Landscape by Players

  • 3.1 Transdermal Skin Patch Sales by Manufacturers
    • 3.1.1 Transdermal Skin Patch Sales by Manufacturers (2015-2020)
    • 3.1.2 Transdermal Skin Patch Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Transdermal Skin Patch Revenue by Manufacturers
    • 3.2.1 Transdermal Skin Patch Revenue by Manufacturers (2015-2020)
    • 3.2.2 Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Transdermal Skin Patch Revenue in 2019
    • 3.2.5 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Transdermal Skin Patch Price by Manufacturers
  • 3.4 Transdermal Skin Patch Manufacturing Base Distribution, Product Types
    • 3.4.1 Transdermal Skin Patch Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Transdermal Skin Patch Product Type
    • 3.4.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Transdermal Skin Patch Market Size by Type (2015-2020)
    • 4.1.1 Global Transdermal Skin Patch Sales by Type (2015-2020)
    • 4.1.2 Global Transdermal Skin Patch Revenue by Type (2015-2020)
    • 4.1.3 Transdermal Skin Patch Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Transdermal Skin Patch Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Transdermal Skin Patch Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
    • 4.2.3 Transdermal Skin Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Transdermal Skin Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Transdermal Skin Patch Market Size by Application (2015-2020)
    • 5.1.1 Global Transdermal Skin Patch Sales by Application (2015-2020)
    • 5.1.2 Global Transdermal Skin Patch Revenue by Application (2015-2020)
    • 5.1.3 Transdermal Skin Patch Price by Application (2015-2020)
  • 5.2 Transdermal Skin Patch Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Transdermal Skin Patch Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Transdermal Skin Patch Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Transdermal Skin Patch by Country
    • 6.1.1 North America Transdermal Skin Patch Sales by Country
    • 6.1.2 North America Transdermal Skin Patch Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Transdermal Skin Patch Market Facts & Figures by Type
  • 6.3 North America Transdermal Skin Patch Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Transdermal Skin Patch by Country
    • 7.1.1 Europe Transdermal Skin Patch Sales by Country
    • 7.1.2 Europe Transdermal Skin Patch Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Transdermal Skin Patch Market Facts & Figures by Type
  • 7.3 Europe Transdermal Skin Patch Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Transdermal Skin Patch by Region
    • 8.1.1 Asia Pacific Transdermal Skin Patch Sales by Region
    • 8.1.2 Asia Pacific Transdermal Skin Patch Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Type
  • 8.3 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Transdermal Skin Patch by Country
    • 9.1.1 Latin America Transdermal Skin Patch Sales by Country
    • 9.1.2 Latin America Transdermal Skin Patch Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Transdermal Skin Patch Market Facts & Figures by Type
  • 9.3 Central & South America Transdermal Skin Patch Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Transdermal Skin Patch by Country
    • 10.1.1 Middle East and Africa Transdermal Skin Patch Sales by Country
    • 10.1.2 Middle East and Africa Transdermal Skin Patch Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Type
  • 10.3 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Hisamitsu Pharmaceutical
    • 11.1.1 Hisamitsu Pharmaceutical Corporation Information
    • 11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
    • 11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
    • 11.1.5 Hisamitsu Pharmaceutical Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description, Business Overview and Total Revenue
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Transdermal Skin Patch Products Offered
    • 11.2.5 Novartis Recent Development
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Corporation Information
    • 11.3.2 Johnson & Johnson Description, Business Overview and Total Revenue
    • 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered
    • 11.3.5 Johnson & Johnson Recent Development
  • 11.4 Teikoku Pharma
    • 11.4.1 Teikoku Pharma Corporation Information
    • 11.4.2 Teikoku Pharma Description, Business Overview and Total Revenue
    • 11.4.3 Teikoku Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered
    • 11.4.5 Teikoku Pharma Recent Development
  • 11.5 Mylan
    • 11.5.1 Mylan Corporation Information
    • 11.5.2 Mylan Description, Business Overview and Total Revenue
    • 11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Mylan Transdermal Skin Patch Products Offered
    • 11.5.5 Mylan Recent Development
  • 11.6 Actavis
    • 11.6.1 Actavis Corporation Information
    • 11.6.2 Actavis Description, Business Overview and Total Revenue
    • 11.6.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Actavis Transdermal Skin Patch Products Offered
    • 11.6.5 Actavis Recent Development
  • 11.7 Mundipharma
    • 11.7.1 Mundipharma Corporation Information
    • 11.7.2 Mundipharma Description, Business Overview and Total Revenue
    • 11.7.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Mundipharma Transdermal Skin Patch Products Offered
    • 11.7.5 Mundipharma Recent Development
  • 11.8 Henan Lingrui Pharmaceutical
    • 11.8.1 Henan Lingrui Pharmaceutical Corporation Information
    • 11.8.2 Henan Lingrui Pharmaceutical Description, Business Overview and Total Revenue
    • 11.8.3 Henan Lingrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered
    • 11.8.5 Henan Lingrui Pharmaceutical Recent Development
  • 11.9 Changzhou Siyao
    • 11.9.1 Changzhou Siyao Corporation Information
    • 11.9.2 Changzhou Siyao Description, Business Overview and Total Revenue
    • 11.9.3 Changzhou Siyao Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered
    • 11.9.5 Changzhou Siyao Recent Development
  • 11.10 Rfl Pharmaceutical
    • 11.10.1 Rfl Pharmaceutical Corporation Information
    • 11.10.2 Rfl Pharmaceutical Description, Business Overview and Total Revenue
    • 11.10.3 Rfl Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered
    • 11.10.5 Rfl Pharmaceutical Recent Development
  • 11.1 Hisamitsu Pharmaceutical
    • 11.1.1 Hisamitsu Pharmaceutical Corporation Information
    • 11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
    • 11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
    • 11.1.5 Hisamitsu Pharmaceutical Recent Development
  • 11.12 Purdue Pharma L.P.
    • 11.12.1 Purdue Pharma L.P. Corporation Information
    • 11.12.2 Purdue Pharma L.P. Description, Business Overview and Total Revenue
    • 11.12.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Purdue Pharma L.P. Products Offered
    • 11.12.5 Purdue Pharma L.P. Recent Development
  • 11.13 Teva Pharmaceutical Industries Ltd.
    • 11.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
    • 11.13.2 Teva Pharmaceutical Industries Ltd. Description, Business Overview and Total Revenue
    • 11.13.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Teva Pharmaceutical Industries Ltd. Products Offered
    • 11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Transdermal Skin Patch Market Estimates and Projections by Region
    • 12.1.1 Global Transdermal Skin Patch Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Transdermal Skin Patch Revenue Forecast by Regions 2021-2026
  • 12.2 North America Transdermal Skin Patch Market Size Forecast (2021-2026)
    • 12.2.1 North America: Transdermal Skin Patch Sales Forecast (2021-2026)
    • 12.2.2 North America: Transdermal Skin Patch Revenue Forecast (2021-2026)
    • 12.2.3 North America: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Transdermal Skin Patch Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Transdermal Skin Patch Sales Forecast (2021-2026)
    • 12.3.2 Europe: Transdermal Skin Patch Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Transdermal Skin Patch Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Transdermal Skin Patch Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Transdermal Skin Patch Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Transdermal Skin Patch Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Transdermal Skin Patch Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Transdermal Skin Patch Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Transdermal Skin Patch Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Transdermal Skin Patch Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Transdermal Skin Patch Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Transdermal Skin Patch Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Transdermal Skin Patch Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Transdermal Skin Patch Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Transdermal Skin Patch market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Transdermal Skin Patch market is segmented into
    Fentanyl Transdermal Skin Patch
    Nicotine Transdermal Skin Patch
    Clonidine Transdermal Skin Patch
    Buprenorphine Transdermal Skin Patch

    Segment by Application, the Transdermal Skin Patch market is segmented into
    Relieve Severe Pain
    Stop Smoking Cigarettes
    Treat An Overactive Bladder
    Others

    Regional and Country-level Analysis
    The Transdermal Skin Patch market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Transdermal Skin Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Transdermal Skin Patch Market Share Analysis
    Transdermal Skin Patch market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Skin Patch business, the date to enter into the Transdermal Skin Patch market, Transdermal Skin Patch product introduction, recent developments, etc.
    The major vendors covered:
    Hisamitsu Pharmaceutical
    Novartis
    Johnson & Johnson
    Teikoku Pharma
    Mylan
    Actavis
    Mundipharma
    Henan Lingrui Pharmaceutical
    Changzhou Siyao
    Rfl Pharmaceutical
    Luye Pharma Group Ltd.
    Purdue Pharma L.P.
    Teva Pharmaceutical Industries Ltd.

    Buy now